Ribociclib succinate side effects

In Ribociclib clinical studies, the most common (≥20%) adverse reactions (including laboratory abnormalities) included leukopenia, Neutropenia, decreased hemoglobin, lymphopenia, increased aspartate aminotransferase, increased gamma-glutamyl transferase, increased alanine aminotransferase, infection, nausea, increased creatinine, fatigue, thrombocytopenia, diarrhea, vomiting, headache, constipation, alopecia. Adverse events such as interstitial lung disease/pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) have also occurred after Riboxil was put on the market.